Breast tomosynthesis: a fine balance between benefits and harms in breast cancer screening

Meagan E Brennan
Med J Aust 2019; 211 (8): . || doi: 10.5694/mja2.50359
Published online: 21 October 2019

Many questions need to be discussed before 3D‐mammography is adopted for standard screening

In this issue of the MJA, Houssami and colleagues report the first prospective trial of breast tomosynthesis screening in the Australian BreastScreen program. They found that tomosynthesis has a higher cancer detection rate (CDR) than standard mammography; the trade‐offs were a higher recall rate, higher radiation dose, and longer reading time.1

  • Meagan E Brennan1,2

  • 1 Northern and Westmead Clinical Schools, University of Sydney, Sydney, NSW
  • 2 The University of Notre Dame, Sydney, NSW

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.